Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. April 2020 16:05 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020

HAUPPAUGE, N.Y., April 27, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
15. April 2020 09:26 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Receives Emergency Use Authorization for DPP COVID-19 System for IgG and IgM Antibodies

First Shipments of the COVID-19 Serological Test have been Released HAUPPAUGE, N.Y., April 15, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care...
09. April 2020 16:05 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics and Stony Brook Medicine Collaborate to Identify Coronavirus Survivors

HAUPPAUGE, N.Y., April 09, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its DPP...
08. April 2020 08:00 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Receives Second UNICEF Order for $1.5 Million

HAUPPAUGE, N.Y., April 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a...
31. März 2020 21:10 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Announces Launch of DPP COVID-19 Serological Point-of-Care Test

HAUPPAUGE, N.Y., March 31, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the U.S....
20. März 2020 08:30 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

HAUPPAUGE, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today reported that, in...
20. März 2020 08:00 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Receives $4 Million Purchase Order from Bio-Manguinhos for Production of DPP COVID-19 IgM/IgG System in Brazil

HAUPPAUGE, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its receipt...
12. März 2020 16:46 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Appoints Richard Eberly As Chief Executive Officer

HAUPPAGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the...
12. März 2020 16:07 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Fourth Quarter and Full Year 2019 Financial Results

HAUPPAUGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
12. März 2020 08:00 ET | Quelle: Chembio Diagnostics, Inc.

Chembio and LumiraDx Announce COVID-19 Strategic Partnership

HAUPPAUGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that it has...

Vorherige Seite

Nächste Seite